The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface.
Mutations in virtually all of the proteins comprising the cardiac muscle sarcomere have been implicated in causing Familial Hypertrophic Cardiomyopathy (FHC). Mutations in the beta-myosin heavy chain (MHC) remain among the most common causes of FHC, with the widely studied R403Q mutation resulting i...
Main Authors: | Niels Volkmann, Hongjun Lui, Larnele Hazelwood, Kathleen M Trybus, Susan Lowey, Dorit Hanein |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-11-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2040505?pdf=render |
Similar Items
-
Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
by: Toepfer, C, et al.
Published: (2019) -
Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
by: Chiara Foglieni, et al.
Published: (2022-09-01) -
Biomechanical response of ultrathin slices of hypertrophic cardiomyopathy tissue to myosin modulator mavacamten
by: Jorik H. Amesz, et al.
Published: (2024-01-01) -
The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients with Symptomatic Hypertrophic Cardiomyopathy
by: Mohammand Yassen
Published: (2023-05-01) -
Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function
by: Makenna M Morck, et al.
Published: (2022-06-01)